AtaGenix Laboratories was established in Biolake Wuhan, the National BioIndustrial Park in 2012. By working closely with its sister company (ProteoGenix Laboratories) in Strasbourg France, AtaGenix has been pushing forward technologies which are involved in recombinant protein expression and purification (Xten CHO expression system), antibody discoveries (Premium human scFv naïve library, 10^11pfu), antibody engineering and stable cell line development. With the current available technologies, our clients, including top pharmas, universities and government bodies across the world, are able to start from an idea to significant industrialization stages, such as immunodiagnostic antibodies for IVD, humanized therapeutic antibodies, industrial enzymes and process development.